Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01565135 · ClinicalTrials.gov registry record · NA
Immunization Delivery in Obstetrics and Gynecology Settings
A NA study of Immunization Status Among Obstetrics and Gynecology Patients, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 97,087
- Enrollment target
- 1
- Study location
NCT01565135: Completed NA study of Immunization Status Among Obstetrics and Gynecology Patients, sponsored by University of Colorado, Denver.
NCT01565135 is a NA study of Immunization Status Among Obstetrics and Gynecology Patients that has completed, run by University of Colorado, Denver. The registered enrollment target is 97,087 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (6825% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01565135, a NA study of Immunization Status Among Obstetrics and Gynecology Patients, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 97,087 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if a multimodal immunization program carried out in obstetrics and gynecology (ob/gyn) practices would be more effective in improving ob/gyn patients' immunization rates, specifically for Tdap (Tetanus, Diphtheria, Pertussis), HPV (Human papilloma virus), and influenza vaccines, than the usual care provided to patients in ob/gyn practices.
Primary Outcome
The percent of eligible patients presenting for care who receive Tdap vaccine will be assessed one year prior to the intervention and 12 and 21 months after the intervention. This assessment will occur in both intervention and control settings using two data sources 1) administrative data and 2) patient self-report of vaccine history.
Conditions Studied
Interventions
- BEHAVIORAL Multimodal Vaccine Program
Study Locations (1)
Colorado
- University of Colorado Denver - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97,087 participants |
| Start Date | 2012-09 |
| Est. Completion | 2015-10 |
| Phase | NA |
What the finished NCT01565135 record still lists
NCT01565135 is an interventional study that assigns participants to a tested intervention. Its 97,087 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (6825% higher).
The record links to 1 condition, with Immunization Status Among Obstetrics and Gynecology Patients appearing as the primary indexed condition, and to 1 intervention - of which Multimodal Vaccine Program is the first listed.
NCT01565135 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01565135 about?
NCT01565135 is a clinical study titled "Immunization Delivery in Obstetrics and Gynecology Settings". The purpose of this study is to determine if a multimodal immunization program carried out in obstetrics and gynecology (ob/gyn) practices would be more effective in improving ob/gyn patients' immunization rates, specifically for Tdap (Tetanus, Diphtheria, Pertussis), HPV (Human papilloma virus), an...
What is the current status of trial NCT01565135?
This trial is currently completed. It is a NA study. The enrollment target is 97,087 participants. The study started on 2012-09. Estimated completion is 2015-10.
What conditions does trial NCT01565135 study?
This clinical trial studies the following conditions: Immunization Status Among Obstetrics and Gynecology Patients.
What interventions are being tested in trial NCT01565135?
The interventions under investigation include: Multimodal Vaccine Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01565135?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01565135 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01565135's enrollment target sits among peer trials
97,087 3rd of 2000 higher than 1,998 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01351545 · 99,999 participants
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia